No. 806-808, Building 3, Forte Pujiang Center, Lane 1505, Lianhang Road, Pujiang Town, Minhang District, Shanghai, China 0086-15372315218 henry@dehuangroup.com henry 2853528822
Vermont is turning over oversight of industrial hemp cultivation to the U.S. Department of Agriculture and creating a separate state agency to oversee hemp products before opening the adult-use hemp market this fall.
Since cannabis was removed from the list of banned narcotics, the Southeast Asian country has seen an explosion in cannabis products. New supply chains are rapidly emerging with products based on cannabis and its derivatives, from hot sauce and gummy bears to cannabis tea and pre-rolled cigarettes.
With Cresco Labs' impending acquisition of New York-based multistate cannabis operator Columbia Care, its co-founder and longtime CEO Nicholas Vita could exit with more than $100 million in cash and stock.
A group of U.S. senators is trying to ramp up pressure on the Biden administration to remove marijuana from the federal Controlled Substances Act, citing previous promises of reform.
Cannabis technology company Akerna completed a public offering of stock and stock purchase warrants, raising about $10 million in gross proceeds for debt service and other purposes.
Lauterbach confirmed that the government aims to complete a draft law by the end of this year, but did not provide new details about when the legislation will be approved and regulations issued.
Perhaps the most groundbreaking in the growing body of cannabis research are the companies that have licenses issued by the DEA. Depending on the license category, these companies can legally cultivate, manufacture, import, export, analyze and conduct cannabis research.
The U.S. Food and Drug Administration FDA authorized Connecticut-based CT Pharma to grow marijuana in 2019 for a study at Yale University.CT Pharma was one of four companies in the state to receive a license to grow medical marijuana, making headlines in 2019.
Marijuana companies may soon have the option of placing TV ads without fear of federal intervention under a new bill introduced by the U.S. House Appropriations Committee.
All marijuana consumers in the nation's capital will no longer need a doctor's recommendation to visit seven medical marijuana dispensaries in Washington, D.C.
They scored legislative victories in Rhode Island, Mississippi and Maryland, setting the stage for hundreds of millions of dollars in combined sales for recreational and medical marijuana companies in those states.